Micallef Jacob Vincent's Form 4 filing
Volitionrx Ltd (VNRX) · filed Aug 31, 2023
- Accession no.
- 0001477932-23-006539
- Filed
- Aug 31, 2023
- Trade date
- Aug 29-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $25.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Micallef Jacob VincentCIK 0001651671 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 | Common Stock | PPurchaseAcquired | +11,250 | $1.24 | +$13,950 | 46,250 | Indirect | |
| Aug 30, 2023 | Common Stock | PPurchaseAcquired | +8,750 | $1.27 | +$11,112.5 | 55,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.